Investors Asset Management of Georgia’s AstraZeneca AZN Stock Holding History

Investors Asset Management of Georgia’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.42M	Hold	7,467	–	–	0.49%	57
2026 Q1	$1.47M	Buy	7,467 +172	+2%	+$33.2K	0.6%	52
2025 Q4	$1.34M	Hold	7,295	–	–	0.55%	52
2025 Q3	$1.12M	Sell	7,295 -25	-0.3%	-$3.78K	0.48%	62
2025 Q2	$1.02M	Hold	7,320	–	–	0.47%	64
2025 Q1	$1.08M	Sell	7,320 -350	-5%	-$50.6K	0.54%	57
2024 Q4	$1.01M	Sell	7,670 -200	-3%	-$28K	0.49%	60
2024 Q3	$1.23M	Sell	7,870 -50	-0.6%	-$8.07K	0.58%	51
2024 Q2	$1.24M	Sell	7,920 -25	-0.3%	-$3.76K	0.6%	54
2024 Q1	$1.08M	Hold	7,945	–	–	0.51%	61
2023 Q4	$1.07M	Hold	7,945	–	–	0.54%	58
2023 Q3	$1.05M	Hold	7,945	–	–	0.58%	53
2023 Q2	$1.14M	Hold	7,945	–	–	0.59%	50
2023 Q1	$1.1M	Sell	7,945 -1,000	-11%	-$135K	0.59%	51
2022 Q4	$1.21M	Hold	8,945	–	–	0.63%	48
2022 Q3	$981K	Sell	8,945 -50	-0.6%	-$6.34K	0.51%	54
2022 Q2	$1.19M	Sell	8,995 -150	-2%	-$19.7K	0.62%	43
2022 Q1	$1.21M	Hold	9,145	–	–	0.61%	47
2021 Q4	$1.06M	Sell	9,145 -50	-0.5%	-$5.88K	0.51%	54
2021 Q3	$1.1M	Hold	9,195	–	–	0.57%	51
2021 Q2	$1.1M	Hold	9,195	–	–	0.59%	46
2021 Q1	$914K	Hold	9,195	–	–	0.53%	54
2020 Q4	$919K	Sell	9,195 -88	-0.9%	-$9.32K	0.62%	45
2020 Q3	$1.02M	Hold	9,283	–	–	0.68%	37
2020 Q2	$982K	Hold	9,283	–	–	0.68%	35
2020 Q1	$829K	Sell	9,283 -550	-6%	-$51.8K	0.68%	36
2019 Q4	$980K	Sell	9,833 -200	-2%	-$18.8K	0.59%	40
2019 Q3	$894K	Sell	10,033 -175	-2%	-$15.2K	0.57%	39
2019 Q2	$843K	Buy	10,208 +50	+0.5%	+$3.92K	0.57%	45
2019 Q1	$821K	Buy	10,158 +150	+1%	+$11.8K	0.57%	48
2018 Q4	$760K	Buy	10,008 +50	+0.5%	+$3.9K	0.62%	43
2018 Q3	$788K	Hold	9,958	–	–	0.55%	53
2018 Q2	$699K	Sell	9,958 -50	-0.5%	-$3.6K	0.51%	55
2018 Q1	$700K	Hold	10,008	–	–	0.52%	52
2017 Q4	$695K	Sell	10,008 -137	-1%	-$9.24K	0.49%	51
2017 Q3	$687K	Buy	10,145 +525	+5%	+$33.2K	0.51%	50
2017 Q2	$656K	Buy	9,620 +350	+4%	+$22.9K	0.45%	52
2017 Q1	$577K	Buy	9,270 +1,245	+16%	+$72.5K	0.4%	58
2016 Q4	$438K	Buy	8,025 +1,742	+28%	+$98.9K	0.32%	69
2016 Q3	$413K	Buy	+6,283	New	+$411K	0.31%	70

Other funds holding AZN

Evelyn Partners London $46.9B AUM

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Investors Asset Management of Georgia's AZN Position: Q2 2026 in Review

Investors Asset Management of Georgia held its AstraZeneca (AZN) position steady in Q2 2026 at 7,467 shares worth $1.42M. The position accounts for 0.49% of the portfolio, ranked #57.

Investors Asset Management of Georgia first reported a position in AZN in Q3 2016 and has held it in 40 quarters since. The position peaked at $1.47M in Q1 2026. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

Investors Asset Management of Georgia held 7,467 shares of AstraZeneca worth $1.42M as of Q2 2026.
Investors Asset Management of Georgia left its AstraZeneca share count unchanged in Q2 2026.
AstraZeneca made up 0.49% of Investors Asset Management of Georgia's portfolio in Q2 2026, its #57 holding.
Investors Asset Management of Georgia first reported a position in AstraZeneca in Q3 2016 and has held it in 40 quarters since.
Investors Asset Management of Georgia's AstraZeneca position peaked at $1.47M in Q1 2026.
1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Investors Asset Management of Georgia's 13F filing for Q2 2026, filed 22 Jul 2026.